
A Pyroptosis-Related LncRNA Signature for Predicting Prognosis, Immune Features and Drug Sensitivity in Ovarian Cancer
Introduction Worldwide, ovarian cancer (OC) ranks as the third most common gynecologic cancer and patients with OC suffer from an extremely high recurrence and mortality rate.1 In 2023, there were 19,710 new cases and 13,270 deaths of OC in the United …